Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
consequences associated with this gene modulation in producing functional efficacy, with the goal of bringing this therapy to clinical application. The private foundation funded project involves extensive, fast
-
The University of Nevada, Las Vegas invites applications for Administrative Assistant 3, Occupational Therapy Doctorate Program, School of Integrated Health Sciences [R0148818]. ROLE of the POSITION
-
consequences of its mutation in cancers. Summary aim: This project will investigate the nuclear function of TPL-2 kinase. Techniques: Cell culture, protein-protein interaction studies, CRISPR/Cas9 gene editing
-
(advanced cardiac therapies), heart rhythm disorders (arrhythmia), and risk factor reduction. Together our team of physicians, nurse practitioners, registered nurses, licensed vocational nurses, device
-
(CVPF) and Center for Advanced Cellular Therapies (CACT) of the University of Pennsylvania manufacture advanced cell and gene therapy products in support of pioneering investigational new drug (IND
-
specializes in drug discovery and development, particularly targeting chromatin remodeling enzymes and synthetic lethality pathways for cancer therapy. The company leverages its molecular expertise in
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 days ago
several creative scientists in fundamental molecular, cellular and computational areas applicable to cancer etiology, progression, metastasis and therapy. Areas of interest include but are not limited
-
preclinical assessment of DNA repair inhibitors in combination with tumour treating fields (TTFields) therapy with a focus on in vivo assessment, following recent promising cell-based studies by our team
-
protein expression in cells from tissues of women at high risk for cancer, and to identify differences in tumor responses to cancer therapies. Using biological knowledge, identify candidate cell
-
for gene-specific therapy, yet their clinical use is hindered by challenges such as limited stability, inefficient delivery, and off-target effects. Project 1: In this B cell-disease oriented project we aim